JAN 31, 2017 10:00 AM PST

WEBINAR: The Vital Role of Transformative Diagnostics in Optimizing Antimicrobial Stewardship

SPONSORED BY: T2 Biosystems, Inc.
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Chief Medical Officer, T2 Biosystems and Professor Emeritus Departments of Pathology and Epidemiology University of Iowa College of Medicine and College of Public Health
    Biography
      Dr. Pfaller is an accomplished physician, educator, and researcher in the areas of antifungal agents and resistance, epidemiology of bacterial and fungal infections, and the role of the clinical microbiology laboratory in hospital infection control. He is a co-editor in chief of the 11th edition of ASM Manual of Clinical Microbiology and co-author of Medical Microbiology, 7th Edition and has authored over 700 articles in peer-reviewed journals. Dr. Pfaller currently serves as Chief Medical Officer at T2 Biosystems.

    Abstract:

    DATE: January 31, 2017
    TIME: 10:00am PT/1:00pm ET

    Learn from renowned clinical expert, Dr. Michael A. Pfaller, as he discusses the critical role of diagnostics and antimicrobial stewardship in improving patient outcomes and reducing overall healthcare costs.  

    Dr. Pfaller will discuss how a robust antimicrobial stewardship program, when coupled with transformative diagnostic tools such as T2MR® and the T2Candida® Panel, offers clinicians the opportunity for early, targeted antimicrobial interventions with the potential to improve patient outcomes and reduce healthcare costs. 

    Dr. Pfaller will also review current best practices for diagnosing and managing patients at risk for sepsis and provide an overview of forthcoming rapid, highly sensitive, direct-from-blood diagnostics.

    Learning Objectives:

    • Understand the critical role of diagnostics and antimicrobial stewardship in improving patient outcomes for patients at high risk for sepsis and invasive candidiasis
    • Understand the potential of rapid diagnostics, such as the T2Candida® Panel and T2Dx® Instrument, to improve patient outcomes and reduce healthcare costs through the timely detection of deadly sepsis pathogens

    Show Resources
    You May Also Like
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    JUN 26, 2018 06:00 AM PDT
    C.E. CREDITS
    JUN 26, 2018 06:00 AM PDT
    Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
    JUN 20, 2018 10:00 AM EDT
    C.E. CREDITS
    JUN 20, 2018 10:00 AM EDT
    DATE: June 20, 2018TIME: 07:00AM PDT, 10:00AM EDTIntroducing GE’s New Lyo-StableTM service. Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes...
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    SEP 12, 2017 08:00 AM PDT
    SEP 12, 2017 08:00 AM PDT
    DATE: September 12, 2017TIME: 8:00am PT, 11:00am ETEvery year, millions of dollars are wasted on poorly characterized and performing antibodies.  Key researchers in the antibody co...
    Loading Comments...